|
|
|
Form Approved
OMB No. 0920-New
Expiration Date: XX/XX/XXXX
mChoice: Improving PrEP Uptake and Adherence among Minority MSM through Provider Training and Adherence Assistance in Two High Priority Settings
Attachment 4f
Patient Interview Guide English
Public reporting burden of this collection of information is estimated to average 90 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer; 1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30333; Attn: OMB-PRA (0920-New)
Protocol: AAAT8812 Study: mChoice: Improving PrEP Uptake and Adherence among Minority MSM through Tailored Provider Training and Adherence Assistance in Two High Priority Settings |
mChoice Study and CleverCap App Follow-up Interview Guide:
INTRODUCTION: This interview is to help us understand your thoughts about your participation in the mChoice study and using the CleverCap app and CleverCap pill bottle [only if participant is/was on oral PrEP]. I’ll be asking you open-ended interview questions. There are no right or wrong answers. The interview will last about 1 hour and will be recorded. We will make every effort to protect your privacy and confidentiality by keeping your responses confidential and not recording any of your identifiable information. Before we start, please remember that your participation is voluntary, meaning that you do not have to answer any question that makes you uncomfortable, and you may stop at any time.
In the following questions, I will be asking you about your experience with the mChoice study. When I say mChoice study, I mean the 6 study visits you completed at [site] and your use of the CleverCap app and CleverCap pill bottle. Do you have any questions before we begin?
|
End of Interview This is the end of the interview today. Before we wrap up, is there anything else you would like to share with me? Thank you for your time. |
|
|
|
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
File Title | Microsoft Word - mChoice_Aim 2_Interview Guide_Patients_9.2.2021.docx |
Author | Emma Sophia Kay |
File Modified | 0000-00-00 |
File Created | 2024-07-20 |